BioSpace News Archive

Drug Development

Biophytis Announces Very Promising Top Line Results of its Phase 2-3 COVA Clinical Study in COVID-19-Related Respiratory Failure

Biophytis SA released top-line results from its phase 2-3 COVA clinical study evaluating Sarconeos in the treatment of COVID-19-related respiratory failure.

September 7, 2022
·
7 min read
Drug Development

Ionis presents positive results from Phase 3 NEURO-TTRansform study at International Symposium on Amyloidosis

Ionis Pharmaceuticals, Inc. presented positive results from a planned 35-week interim analysis of the Phase 3 NEURO-TTRansform study of Ionis and AstraZeneca’s eplontersen in patients with hereditary transthyretin-mediated amyloid polyneuropathy.

September 7, 2022
·
7 min read
Bio NC

Inivata and Collaborators to Present New Data to Support the Application of RaDaR™ MRD Assay Across Tumor Types at ESMO Congress 2022

Inivata, a leader in liquid biopsy, alongside collaborators, will present new data on its RaDaR™ assay for the detection of minimal residual disease and recurrence at the European Society for Medical Oncology Congress, taking place on 9-13 September 2022.

September 7, 2022
·
4 min read
Business

Mainz Biomed Reports First Half 2022 Financial Results

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced financial results for the first half of the fiscal year ended June 30, 2022.

September 7, 2022
·
15 min read
George Medicines provides single-pill triple combination candidate for hypertension to VERONICA-Nigeria trial

George Medicines announced that its novel single-pill, triple combination candidate, GMRx2, is being used in the VERONICA-Nigeria trial as a novel treatment for hypertension.

September 7, 2022
·
8 min read
Salipro Biotech Obtains Granted Patents in the United States and China for Direct Extraction of Membrane Proteins and Library Generation

Salipro Biotech AB announced that its patent entitled “Saposin lipoprotein particles and libraries from crude membranes” has been issued by both the U.S. Patent and Trademark Office and by the China National Intellectual Property Administration.

September 7, 2022
·
2 min read
Carroucell Raises €1.5 Million to Introduce Breakthrough Microcarriers and Customizable Processes to Cell and Gene Therapy Market

Carroucell, the microcarrier supplier for cell culture in bioreactor, announced that it has raised a total of €1.5 million.

September 7, 2022
·
3 min read
Philips announces new milestones in the development of the world’s first spectral detector angio CT solution

Royal Philips, a global leader in health technology, announced new milestones in the development of the world’s first spectral detector angio CT solution - Philips Spectral Angio CT suite - bringing the company’s breakthrough spectral CT imaging technology into an integrated hybrid angio CT suite.

September 7, 2022
·
6 min read
Business

OncoOne Expands Scientific Advisory Board Adding Three World-Renowned MIF and Macrophage Experts to Support Upcoming Clinical Programs

OncoOne announced the appointment of three new members to its scientific advisory board to accelerate the clinical development of the company’s oxidized macrophage migration inhibitory factor -targeting pipeline.

September 7, 2022
·
5 min read
BioMidwest

BioVie and Dr. Sheldon Jordan Jointly Announce Topline Results from an Investigator-Sponsored Exploratory Biomarker and Imaging Trial of NE3107 for the Treatment of Alzheimer’s Disease

BioVie Inc., a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative disorders, announced topline results from an investigator-Sponsored Phase 2 clinical trial of NE3107 for the treatment of Alzheimer’s Disease.

September 7, 2022
·
17 min read